Bevacizumab in the treatment of non-small cell lung cancer with brain metastases / 国际肿瘤学杂志

The occurrence of brain metastases in lung cancer affects the prognosis of patients.Following surgery,whole brain radiotherapy,stereotactic radiotherapy and chemotherapy,anti-angiogenesis therapy has become a new treatment option for lung cancer patients with brain metastases.As an anti-angiogenic drug,bevacizumab has a better effect of controlling peritumoral edema.Studies have shown that bevacizumab combined with chemotherapy,radiotherapy to treat non-small cell lung cancer with brain metastasis has a good efficacy and safety.